A randomised controlled trial of calcium channel blockade (CCB) with Amlodipine For the treatment oF subcortical ischaEmic vasCular demenTia (AFFECT): study protocol
Peter Passmore(Queen's University Belfast), Rob Jones(University of Nottingham), Martín Knapp(London School of Economics and Political Science), Patrick G. Kehoe(University of Bristol), Clive Ballard(University of Exeter), Alan Thomas(Cleveland Clinic), Catherine Henderson(London School of Economics and Political Science), Ly‐Mee Yu(Dartmouth–Hitchcock Medical Center), Bernadette McGuinness(Queen's University Belfast), Rachel Canning(Alzheimer's Society), Clive Holmes(University of Eastern Finland), Robert Stewart(Heriot-Watt University), Frank Arrojo(Alzheimer's Society), Philip M. Bath(Nottingham University Hospitals NHS Trust), Caroline Greenan(University of Ulster), Peter Connelly(Queen's University Belfast), Sylvia Wallach(Alzheimer's Society), Anne Corbett(University of Exeter), Elizabeth Coulthard(North Bristol NHS Trust), Lynn Murphy(Belfast Health and Social Care Trust)
Cited by 11
Related Papers
Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science
|The Lancet Psychiatry|2020|6k
Diagnosis and management of dementia with Lewy bodies
|Neurology|2017|4.4k
Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease
|Nature Genetics|2009|3.4k
A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease
|Alzheimer s & Dementia|2014|3.1k
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease
|Nature Genetics|2011|2.1k